|
US6890539B2
(en)
|
1998-12-22 |
2005-05-10 |
Microscience, Ltd. |
Genes and proteins, and their use
|
|
KR100790653B1
(ko)
|
1998-12-22 |
2007-12-31 |
마이크로싸이언스 리미티드 |
유전자와 단백질들, 및 그들의 사용
|
|
EP1328543B1
(en)
|
2000-10-27 |
2009-08-12 |
Novartis Vaccines and Diagnostics S.r.l. |
Nucleic acids and proteins from streptococcus groups a & b
|
|
JP4875490B2
(ja)
|
2003-07-31 |
2012-02-15 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｙｏｇｅｎｅｓについての免疫原組成物
|
|
US8945589B2
(en)
|
2003-09-15 |
2015-02-03 |
Novartis Vaccines And Diagnostics, Srl |
Immunogenic compositions for Streptococcus agalactiae
|
|
EP1807446A2
(en)
*
|
2004-10-08 |
2007-07-18 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogenic and therapeutic compositions for streptococcus pyogenes
|
|
EP1801235A1
(en)
*
|
2005-12-20 |
2007-06-27 |
Institut Pasteur |
Rapid detection of the "high virulent" ST-17 clone of Group B streptococcus
|
|
JP2009540819A
(ja)
*
|
2006-06-19 |
2009-11-26 |
ミュタビリス エス アー |
Ｂ群レンサ球菌の病原性に関与する遺伝子の同定
|
|
US20100150943A1
(en)
*
|
2006-07-26 |
2010-06-17 |
Novartis Ag |
Immunogenic compositions for gram positive bacteria
|
|
JP5653215B2
(ja)
|
2007-09-12 |
2015-01-14 |
ノバルティス アーゲー |
Ｇａｓ５７変異体抗原およびｇａｓ５７抗体
|
|
EP2135877A1
(en)
|
2008-06-19 |
2009-12-23 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Marker of steptococcus anginosus/Streptococcus constellatus (Moac) and uses thereof
|
|
US8147849B2
(en)
|
2009-02-20 |
2012-04-03 |
Novartis Ag |
Protective antigens for group B Streptococcus hypervirulent strains
|
|
ITMI20090946A1
(it)
|
2009-05-28 |
2010-11-29 |
Novartis Ag |
Espressione di proteine ricombinanti
|
|
AU2010273708B2
(en)
|
2009-06-29 |
2015-10-01 |
Children's Medical Center Corporation |
Vaccines and compositions against Streptococcus pneumoniae
|
|
GB201101665D0
(en)
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|
|
MY163871A
(en)
|
2011-01-20 |
2017-10-31 |
Genocea Biosciences Inc |
Vaccines and compositions against streptococcus pneumoniae
|
|
JP5986931B2
(ja)
*
|
2011-02-02 |
2016-09-06 |
公益財団法人微生物化学研究会 |
血液脳関門を透過する薬物輸送体、ペプチド及びその用途
|
|
EP2557424A1
(en)
*
|
2011-08-11 |
2013-02-13 |
InGen Biosciences |
Method for diagnosing Streptococcus, Enterococcus and Pepstostreptococcus genera infections
|
|
WO2013124473A1
(en)
*
|
2012-02-24 |
2013-08-29 |
Novartis Ag |
Pilus proteins and compositions
|
|
JP6335873B2
(ja)
*
|
2012-03-30 |
2018-05-30 |
イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ |
過酸生成に有用な酵素
|
|
RU2015106791A
(ru)
|
2012-10-03 |
2016-11-20 |
Глэксосмитиклайн Байолоджикалз Са |
Иммуногенные композиции
|
|
EP3021864A1
(en)
*
|
2013-07-16 |
2016-05-25 |
Université de Lausanne |
Bacterial lysins and uses thereof
|
|
AR101455A1
(es)
*
|
2014-08-05 |
2016-12-21 |
Glaxosmithkline Biologicals Sa |
Molécula portadora
|
|
SG11201806639VA
(en)
|
2016-02-04 |
2018-09-27 |
Genovis Ab |
New streptococcal proteases
|
|
WO2018204153A1
(en)
*
|
2017-05-02 |
2018-11-08 |
Venomyx, Inc. |
Composition and methods for treating snake envenomation
|
|
WO2018237010A2
(en)
*
|
2017-06-20 |
2018-12-27 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Vaccine compositions and methods of using the same
|
|
PL239045B1
(pl)
*
|
2018-01-09 |
2021-11-02 |
Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk |
Epitop specyficzny dla zakaźnych Streptococcus agalactiae oraz sposób wykrywania zakażenia pacjenta szczepem Streptococcus agalactiae
|
|
GB2590210B
(en)
*
|
2018-06-13 |
2023-01-25 |
Gen Probe Inc |
Compositions and methods for detecting group B Streptococcus nucleic acid
|
|
RU2021105821A
(ru)
|
2018-08-06 |
2021-05-27 |
Медикайн, Инк. |
Соединения, связывающие рецептор il-2
|
|
WO2021092075A1
(en)
|
2019-11-05 |
2021-05-14 |
Medikine Inc. |
IL-2RβγC BINDING COMPOUNDS
|
|
WO2021108929A1
(en)
*
|
2019-12-06 |
2021-06-10 |
Theratechnologies Inc. |
Sortilin binding conjugate compounds, compositions and uses thereof for treating cancer
|
|
WO2021158623A1
(en)
|
2020-02-03 |
2021-08-12 |
Medikine, Inc. |
IL-7Rαγc BINDING COMPOUNDS
|
|
AU2021219847A1
(en)
*
|
2020-02-12 |
2022-10-13 |
Massachusetts Institute Of Technology |
Field deployable CRISPR-Cas diagnostics and methods of use thereof
|
|
US11453907B2
(en)
|
2020-03-23 |
2022-09-27 |
The Broad Institute, Inc. |
Crispr effector system based coronavirus diagnostics
|
|
WO2022026534A1
(en)
*
|
2020-07-28 |
2022-02-03 |
Kansas State University Research Foundation |
Sars-cov-2 immunogenic compositions and methods for protecting against sars-cov-2 clinical signs
|
|
CA3197344A1
(en)
*
|
2020-11-04 |
2022-05-12 |
William J. Dower |
Il-2r.beta.yc binding compounds and uses thereof
|
|
US11999771B2
(en)
|
2022-04-07 |
2024-06-04 |
Medikine, Inc. |
IL-7Rαγc ligand immunoglobulin fusion proteins
|
|
WO2025017062A1
(en)
*
|
2023-07-18 |
2025-01-23 |
Intervet International B.V. |
New type of streptococcus agalactiae serotype ia bacterium and vaccines thereof
|
|
WO2025151408A1
(en)
*
|
2024-01-08 |
2025-07-17 |
Denali Therapeutics Inc. |
Compositions and methods for modulating tau expression
|